Area of research
Pharmacology · Computational Theory and Mathematics
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods, Epigenetics and DNA Methylation, and Cancer Genomics and Diagnostics.
Pharmacogenetics of Warfarin Dosing in Patients of African and European Ancestry
Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals
Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study
Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users
Genome-wide admixture and association study of subclinical atherosclerosis in the Women’s Interagency HIV Study (WIHS)
Race‐Specific Influence of <i><scp>CYP</scp>4F2</i> on Dose and Risk of Hemorrhage Among Warfarin Users
Race influences warfarin dose changes associated with genetic factors
Imputation of class <scp>I</scp> and <scp>II HLA</scp> loci using high‐density <scp>SNP</scp>s from <scp>I</scp>mmuno<scp>C</scp>hip and their associations with <scp>K</scp>awasaki disease in family‐based study
High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case–parent trio study
Influence of Regular Physical Activity on Warfarin Dose and Risk of Hemorrhagic Complications
FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response
DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease
Role of Activating <i>Fc</i> γ <i>R</i> Gene Polymorphisms in Kawasaki Disease Susceptibility and Intravenous Immunoglobulin Response